Skip to main content
. 2023 Feb 10;6(2):e2255709. doi: 10.1001/jamanetworkopen.2022.55709

Figure 3. Cumulative Incidence of Primary Efficacy End Points.

Figure 3.

The primary efficacy end points was a composite of cardiac death, myocardial infarction, re-revascularization, and stroke. HR indicates hazard ratio; MACE, major adverse cardiovascular event.